BCR is a pioneer in diagnostic testing with two innovative products ready for licensing:
- FiBIR™ (named for Fiber-based Internal Reflection)
- BCR-30-min BI™ a biological indicator for sterilization testing
Chandler, Arizona, May 4, 2016.
Taking sterility testing to higher levels, BCR Corp. announced FDA’s clearance of BCR-30-min BI™, a remarkably simple and rapid Biological Indicator (BI) containing spores of heat-resistant bacteria.
The BCR-30-min BI™ is the first BI that perfectly matches CDC’s definition of an ideal monitoring system:
CDC, Dec. 2009. “An ideal biological monitor of the sterilization process should be easy to use, be inexpensive, not be subject to exogenous contamination, provide positive results as soon as possible after the cycle so that corrective action may be accomplished, and provide positive results only when the sterilization parameters (e.g., steam-time and temperature, and/or saturated steam; ETO-time, temperature, relative humidity and/or ETO concentration) are inadequate to kill microbial contaminates.”
Simple Technology Could Reduce Cost of Fluorescence-based Instrumentation by More than Five-fold
BCR Diagnostics relocates to Chandler, Arizona
BCR Diagnostics awarded $204,630 grant under Qualifying Therapeutic Discovery Project (QTDP) program
BCR Corporation Presents An Innovative Breakthrough Biosensor Platform at National Institutes of Health "Life Sciences Showcase"